TY - JOUR
T1 - Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders
T2 - Protocol Development and Initial Outcome Data
AU - Ellard, Kristen K.
AU - Fairholme, Christopher P.
AU - Boisseau, Christina L.
AU - Farchione, Todd J.
AU - Barlow, David H.
PY - 2010/2
Y1 - 2010/2
N2 - The Unified Protocol (UP) is a transdiagnostic, emotion-focused cognitive-behavioral treatment developed to be applicable across the emotional disorders. The UP consists of 4 core modules: increasing emotional awareness, facilitating flexibility in appraisals, identifying and preventing behavioral and emotional avoidance, and situational and interoceptive exposure to emotion cues. Here we present data from 2 open clinical trials. In the first trial, an initial version of the UP was administered to a heterogeneous clinical sample, yielding significant pre- to posttreatment effects across disorders on a variety of measures. Analyses of clinical significance demonstrated modest results, with 56% of participants achieving responder status and 33% achieving high end-state functioning. Further manual development ensued, resulting in specific modifications and enhancements to core treatment components, and a second trial presents data from an additional pilot study of this revised version of the UP. Results from this trial demonstrated more robust treatment effects, with 73% achieving responder status and 60% achieving high end-state functioning. Results improved further at 6-month follow-up, with 85% classified as treatment responders and 69% achieving high end-state functioning. Implications for the treatment of emotional disorders as well as dimensional conceptualizations of psychopathology are discussed.
AB - The Unified Protocol (UP) is a transdiagnostic, emotion-focused cognitive-behavioral treatment developed to be applicable across the emotional disorders. The UP consists of 4 core modules: increasing emotional awareness, facilitating flexibility in appraisals, identifying and preventing behavioral and emotional avoidance, and situational and interoceptive exposure to emotion cues. Here we present data from 2 open clinical trials. In the first trial, an initial version of the UP was administered to a heterogeneous clinical sample, yielding significant pre- to posttreatment effects across disorders on a variety of measures. Analyses of clinical significance demonstrated modest results, with 56% of participants achieving responder status and 33% achieving high end-state functioning. Further manual development ensued, resulting in specific modifications and enhancements to core treatment components, and a second trial presents data from an additional pilot study of this revised version of the UP. Results from this trial demonstrated more robust treatment effects, with 73% achieving responder status and 60% achieving high end-state functioning. Results improved further at 6-month follow-up, with 85% classified as treatment responders and 69% achieving high end-state functioning. Implications for the treatment of emotional disorders as well as dimensional conceptualizations of psychopathology are discussed.
UR - http://www.scopus.com/inward/record.url?scp=77949273972&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949273972&partnerID=8YFLogxK
U2 - 10.1016/j.cbpra.2009.06.002
DO - 10.1016/j.cbpra.2009.06.002
M3 - Article
C2 - 33762811
AN - SCOPUS:77949273972
SN - 1077-7229
VL - 17
SP - 88
EP - 101
JO - Cognitive and Behavioral Practice
JF - Cognitive and Behavioral Practice
IS - 1
ER -